Search hospitals > New Brunswick > MONCTON
The Moncton Hospital
Claim this profileMONCTON, New Brunswick E1C 6Z8
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lymphoma
Conducts research for Parkinson's disease
95 reported clinical trials
1 medical researcher
Summary
The Moncton Hospital is a medical facility located in MONCTON, New Brunswick. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma, Parkinson's disease and other specialties. The Moncton Hospital is involved with conducting 95 clinical trials across 123 conditions. There are 1 research doctors associated with this hospital, such as Maged M. Salem.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Clinical Trials running at The Moncton Hospital
Breast Cancer
Multiple Myeloma
Chronic Lymphocytic Leukemia
Lung Cancer
Plasma Cell Neoplasm
Lymphoma
Small Cell Lymphoma
Chronic B-Cell Leukemia
Solid Tumors
sac-TMT + Pembrolizumab
for Breast Cancer
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery. The primary objective is to compare sacituzumab tirumotecan plus pembrolizumab to TPC (pembrolizumab or pembrolizumab plus capecitabine) with respect to invasive disease-free survival (iDFS) per investigator assessment. It is hypothesized that sacituzumab tirumotecan plus pembrolizumab is superior to TPC with respect to iDFS per investigator assessment.
Recruiting2 awards Phase 35 criteria
Inavolisib + CDK4/6 Inhibitor + Letrozole
for Breast Cancer
This study will evaluate the efficacy and safety of the combination of inavolisib plus a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) and letrozole versus placebo plus a CDK4/6i and letrozole in the first-line setting in participants with endocrine-sensitive PIK3CA-mutated hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), advanced breast cancer (ABC).
Recruiting1 award Phase 36 criteria
Inavolisib + Phesgo
for Breast Cancer
This trial is testing a new drug called inavolisib combined with Phesgo, which includes three existing drugs. It targets patients with untreated HER2-positive advanced breast cancer. Inavolisib works by blocking growth signals in cancer cells, while Phesgo targets a protein on these cells to stop their growth and spread.
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The Moncton Hospital?
The Moncton Hospital is a medical facility located in MONCTON, New Brunswick. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma, Parkinson's disease and other specialties. The Moncton Hospital is involved with conducting 95 clinical trials across 123 conditions. There are 1 research doctors associated with this hospital, such as Maged M. Salem.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.